Home › Funds › Context Capital Management, LLC › HALO
Context Capital Management, LLC position in HALO
HALOZYME THERAPEUTICS INC · Health Care
Context Capital Management, LLC reported holding 139,811 shares of HALO (HALOZYME THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$15.4M, representing 0.51% of its reported portfolio and ranking #49 among its reported holdings. Context Capital Management, LLC has disclosed HALO holdings in 4 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Context Capital Management, LLC's HALO position evolved
Context Capital Management, LLC first disclosed a stake in HALO in Q3 2023 at 2,000 shares (US$1.9M). The position peaked in Q4 2023 at 2,000,000 shares, worth US$1.86B. Across 4 filings, Context Capital Management, LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 139,811 shares valued at US$15.4M. Notable position changes include a 99900% increase in Q4 2023 (shares rose 10% over the following quarter), a 100% trim in Q1 2024 (shares rose 29% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 2.00K | $1.87M | New |
| Q4 2023 | 2.00M | $1.86B | Add |
| Q1 2024 | 1.00K | $975.71M | Reduce |
| Q3 2026 | 139.81K | $15.44M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About HALO and 13F data
HALO (HALOZYME THERAPEUTICS INC) is a Health Care company. 45 other funds we track also report a position in HALO — the largest reported positions include CONGRESS ASSET MANAGEMENT CO (US$251.9M), SNYDER CAPITAL MANAGEMENT L P (US$187.5M), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (US$178.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding HALO
- CONGRESS ASSET MANAGEMENT CO 2.28M sh · $251.89M · Q3 2026
- SNYDER CAPITAL MANAGEMENT L P 2.40M sh · $187.54M · Q2 2026
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 1.62M sh · $178.46M · Q3 2026
- LOS ANGELES CAPITAL MANAGEMENT LLC 1.58M sh · $174.27M · Q3 2026
- Stephens Investment Management Group LLC 1.41M sh · $156.00M · Q3 2026
- GW&K Investment Management, LLC 1.14M sh · $125.86M · Q3 2026
- WASATCH ADVISORS LP 1.05M sh · $115.88M · Q3 2026
- Boston Trust Walden Corp 1.04M sh · $114.35M · Q3 2026
- LMR Partners LLP 45.00M sh · $65.81M · Q2 2026
More on Context Capital Management, LLC
FAQ
How long has Context Capital Management, LLC held HALO?
Context Capital Management, LLC has disclosed HALO holdings in 4 of the last 13 reported quarters, going back to Q3 2023.
What is Context Capital Management, LLC's current position in HALO?
As of Q3 2026, Context Capital Management, LLC holds 139.81K shares of HALO (HALOZYME THERAPEUTICS INC), valued at $15.44M, representing 0.51% of its reported portfolio and ranking #49.
Has Context Capital Management, LLC been buying or selling HALO?
In the latest 13F filing (Q3 2026), Context Capital Management, LLC newly opened its position in HALO. The position peaked in Q4 2023 at 2.00M shares.
Which other funds hold HALO?
Other major institutional holders of HALO include CONGRESS ASSET MANAGEMENT CO, SNYDER CAPITAL MANAGEMENT L P, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, among 45 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.